Treatment Effectiveness
User reported effectiveness ratings Infliximab (Remicade) for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Arthritis | 33% | 0% | 0% | 33% | 33% | 6 |
| Psoriasis | 50% | 50% | 0% | 0% | 0% | 4 |
| Rheumatoid Arthritis | 9% | 36% | 9% | 45% | 0% | 11 |
Side Effects
User-reported side effects of Infliximab (Remicade)
| Side Effect | Percent of Reports Infliximab (Remicade) |
|---|---|
| Back Pain | 14% |
| Heartburn | 17% |
| Stomach Pain | 11% |
| Flushing | 14% |
| More Powerful Erections | 0% |
| Runny Nose | 15% |
| Vaginal Itching, Burning, and Pain or Other Signs of a Yeast Infection | 18% |
| Weight Gain | 30% |
| White Patches in the Mouth | 6% |
| Headache | 31% |
| Nausea | 11% |
Outcomes
Below is the degree of change seen after Infliximab (Remicade) is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Outcomes Label
Infliximab (Remicade) Info
| Property | Value |
|---|---|
| Variable Name | Infliximab (Remicade) |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-03-23 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 0 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
| Public | true |
| Onset Delay | 30 minutes |
| Unit | Count |
| User Variables | 0 |
| Variable Category | Treatments |
| Variable ID | 93981 |